CDR2 and Ataxia: The term PACA is restricted to those ataxias where an antibody, if present, is not directly involved in the pathogenesis of the ataxia, neither does it act as a marker of another well-characterised immune ataxia (e.g. anti-Yo in the context of paraneoplastic ataxia).